Paricalcitol for reduction of albuminuria in diabetes
- PMID: 21334526
- DOI: 10.1016/S0140-6736(11)60222-5
Paricalcitol for reduction of albuminuria in diabetes
Comment on
-
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.Lancet. 2010 Nov 6;376(9752):1543-51. doi: 10.1016/S0140-6736(10)61032-X. Lancet. 2010. PMID: 21055801 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical